Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2024Annals of Clinical Microbiology and AntimicrobialsOpen Access

Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBugwesa Z. KataleSRSylvia RofaelLELinzy Elton

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Katale et al. (2024) studied this question.

synapsesocial.com/papers/68e5b4efb6db64358754dde1https://doi.org/10.1186/s12941-024-00737-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data2024 · 1 citations
  2. 2Whole genome sequencing for the prediction of resistant tuberculosis strains from northern India2024
  3. 3Applying whole genome sequencing to predict phenotypic drug resistance in <i>Mycobacterium tuberculosis</i> : leveraging 20 years of nationwide data from Denmark2024 · 7 citations
  4. 4Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases2024 · 10 citations
  5. 5Whole Genome Sequencing for Detecting Drug-Resistant Mutations in Mycobacterium tuberculosis in Zimbabwe2025